- Home
- GDEN vs IMTX Comparison
GDEN vs IMTX Comparison
Compare GDEN & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEN | IMTX |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.2M | 1.3B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDEN | IMTX |
|---|---|---|
| Price | $27.12 | $10.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $32.20 | $19.25 |
| AVG Volume (30 Days) | 270.0K | ★ 564.1K |
| Earning Date | 11-06-2025 | 11-17-2025 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $643,485,000.00 | $99,445,031.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.89 | $19.39 |
| P/E Ratio | $132.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.57 | $3.30 |
| 52 Week High | $35.49 | $12.41 |
Technical Indicators
Market Signals| Indicator | GDEN | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 48.23 |
| Support Level | $26.65 | $9.96 |
| Resistance Level | $28.02 | $10.50 |
| Average True Range (ATR) | 0.44 | 0.42 |
| MACD | -0.24 | -0.02 |
| Stochastic Oscillator | 27.07 | 46.53 |
Price Performance
Historical ComparisonAbout GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.